Concepts (216)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Confined Spaces | 1 | 2020 | 6 | 0.830 |
Why?
|
Lymphatic Metastasis | 5 | 2021 | 2951 | 0.690 |
Why?
|
Hematopoietic Stem Cells | 4 | 2022 | 3447 | 0.560 |
Why?
|
Longevity | 1 | 2022 | 1019 | 0.520 |
Why?
|
Mutation | 6 | 2022 | 29262 | 0.420 |
Why?
|
Telomerase | 1 | 2015 | 741 | 0.400 |
Why?
|
Lymph Nodes | 3 | 2021 | 3409 | 0.390 |
Why?
|
Genetic Heterogeneity | 3 | 2020 | 749 | 0.390 |
Why?
|
Colorectal Neoplasms | 3 | 2020 | 6497 | 0.370 |
Why?
|
Phylogeny | 4 | 2020 | 2799 | 0.370 |
Why?
|
Poly G | 2 | 2021 | 7 | 0.360 |
Why?
|
Neoplasm Metastasis | 3 | 2020 | 5112 | 0.350 |
Why?
|
DNA, Neoplasm | 1 | 2014 | 1782 | 0.350 |
Why?
|
Atherosclerosis | 2 | 2021 | 3228 | 0.340 |
Why?
|
Cell Proliferation | 7 | 2021 | 10803 | 0.310 |
Why?
|
Breast Neoplasms | 9 | 2021 | 19800 | 0.290 |
Why?
|
Hematopoiesis | 4 | 2022 | 2015 | 0.280 |
Why?
|
Neoplasms | 6 | 2022 | 20172 | 0.270 |
Why?
|
Promoter Regions, Genetic | 1 | 2015 | 6068 | 0.240 |
Why?
|
Macrophages | 4 | 2019 | 5784 | 0.230 |
Why?
|
Models, Biological | 5 | 2021 | 9907 | 0.230 |
Why?
|
Microsatellite Repeats | 2 | 2015 | 807 | 0.220 |
Why?
|
Colonic Neoplasms | 1 | 2014 | 2535 | 0.220 |
Why?
|
Myelopoiesis | 2 | 2020 | 133 | 0.220 |
Why?
|
Germ Layers | 1 | 2021 | 76 | 0.220 |
Why?
|
Acetylcholine | 1 | 2022 | 615 | 0.200 |
Why?
|
Guanine | 1 | 2021 | 283 | 0.200 |
Why?
|
Neoplasm Seeding | 1 | 2020 | 90 | 0.190 |
Why?
|
Biomass | 1 | 2020 | 115 | 0.190 |
Why?
|
Tumor Microenvironment | 3 | 2021 | 2987 | 0.190 |
Why?
|
Lymphatic Vessels | 1 | 2021 | 323 | 0.170 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2020 | 542 | 0.160 |
Why?
|
Gene Expression Regulation, Developmental | 2 | 2008 | 3813 | 0.160 |
Why?
|
Gene Expression Regulation, Neoplastic | 5 | 2020 | 8638 | 0.160 |
Why?
|
Angiotensins | 1 | 2017 | 131 | 0.160 |
Why?
|
Receptor, erbB-3 | 1 | 2017 | 125 | 0.150 |
Why?
|
INDEL Mutation | 1 | 2017 | 269 | 0.150 |
Why?
|
Physical Conditioning, Animal | 1 | 2019 | 377 | 0.150 |
Why?
|
Mice | 19 | 2022 | 80876 | 0.140 |
Why?
|
DNA | 2 | 2021 | 7172 | 0.140 |
Why?
|
Maytansine | 1 | 2015 | 85 | 0.140 |
Why?
|
Diastole | 1 | 2018 | 836 | 0.140 |
Why?
|
Apolipoproteins E | 1 | 2021 | 1465 | 0.140 |
Why?
|
Aneuploidy | 1 | 2018 | 464 | 0.140 |
Why?
|
Myeloid Cells | 2 | 2020 | 787 | 0.130 |
Why?
|
Receptors, CCR2 | 1 | 2015 | 220 | 0.130 |
Why?
|
Immunotherapy | 2 | 2020 | 4057 | 0.130 |
Why?
|
Animals | 21 | 2022 | 170486 | 0.130 |
Why?
|
Sleep Deprivation | 1 | 2021 | 806 | 0.130 |
Why?
|
Genetic Variation | 2 | 2020 | 6666 | 0.130 |
Why?
|
Embryonic Stem Cells | 1 | 2021 | 1386 | 0.120 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2019 | 823 | 0.120 |
Why?
|
Brain Neoplasms | 3 | 2021 | 8776 | 0.120 |
Why?
|
Disease Susceptibility | 1 | 2019 | 1778 | 0.110 |
Why?
|
Cell Differentiation | 3 | 2021 | 11718 | 0.110 |
Why?
|
Epigenomics | 2 | 2015 | 802 | 0.110 |
Why?
|
Humans | 26 | 2022 | 708843 | 0.110 |
Why?
|
Cell Lineage | 1 | 2021 | 2630 | 0.110 |
Why?
|
Bone Marrow Cells | 1 | 2020 | 2596 | 0.110 |
Why?
|
Mice, Inbred C57BL | 6 | 2021 | 22989 | 0.110 |
Why?
|
Liposarcoma | 1 | 2014 | 308 | 0.110 |
Why?
|
Heart Conduction System | 1 | 2017 | 1030 | 0.110 |
Why?
|
Disease Progression | 2 | 2020 | 13298 | 0.100 |
Why?
|
Bone Marrow | 1 | 2021 | 2938 | 0.100 |
Why?
|
Monocytes | 2 | 2018 | 2660 | 0.090 |
Why?
|
Doxorubicin | 2 | 2012 | 2235 | 0.090 |
Why?
|
Mitosis | 1 | 2014 | 1250 | 0.090 |
Why?
|
Platelet-Derived Growth Factor | 1 | 2011 | 643 | 0.090 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2015 | 862 | 0.080 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2015 | 3714 | 0.080 |
Why?
|
Lymphokines | 1 | 2011 | 966 | 0.080 |
Why?
|
Adenocarcinoma | 2 | 2017 | 6338 | 0.080 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2017 | 2936 | 0.080 |
Why?
|
Neoplasm Proteins | 2 | 2017 | 3773 | 0.080 |
Why?
|
Endothelial Cells | 1 | 2020 | 3417 | 0.080 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2017 | 1481 | 0.080 |
Why?
|
Mice, SCID | 3 | 2018 | 2835 | 0.070 |
Why?
|
Receptors, CXCR4 | 1 | 2011 | 724 | 0.070 |
Why?
|
Receptor, erbB-2 | 1 | 2015 | 2307 | 0.070 |
Why?
|
Liver Regeneration | 1 | 2007 | 221 | 0.070 |
Why?
|
Cohort Studies | 2 | 2020 | 39292 | 0.070 |
Why?
|
Disease Models, Animal | 2 | 2021 | 18375 | 0.070 |
Why?
|
Aging | 2 | 2021 | 8358 | 0.070 |
Why?
|
Heart | 1 | 2018 | 4315 | 0.070 |
Why?
|
Cell Line, Tumor | 6 | 2019 | 16959 | 0.070 |
Why?
|
Transforming Growth Factor beta | 1 | 2012 | 1993 | 0.070 |
Why?
|
Myocardium | 1 | 2018 | 4969 | 0.060 |
Why?
|
Melanoma | 1 | 2021 | 5194 | 0.060 |
Why?
|
Carrier Proteins | 1 | 2017 | 5141 | 0.060 |
Why?
|
RNA, Small Interfering | 3 | 2018 | 3645 | 0.060 |
Why?
|
Mice, Inbred NOD | 2 | 2018 | 1918 | 0.060 |
Why?
|
Neoplasm Staging | 1 | 2017 | 11126 | 0.060 |
Why?
|
Cholinergic Agents | 1 | 2022 | 81 | 0.060 |
Why?
|
Mice, Nude | 3 | 2015 | 3859 | 0.050 |
Why?
|
Kaplan-Meier Estimate | 3 | 2017 | 6765 | 0.050 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2011 | 3006 | 0.050 |
Why?
|
Female | 14 | 2021 | 375205 | 0.050 |
Why?
|
Antineoplastic Agents | 4 | 2017 | 13714 | 0.050 |
Why?
|
Aged, 80 and over | 2 | 2017 | 58184 | 0.050 |
Why?
|
Lymphatic System | 1 | 2021 | 257 | 0.050 |
Why?
|
Inflammation | 1 | 2019 | 10019 | 0.050 |
Why?
|
Gene Expression Profiling | 4 | 2020 | 9556 | 0.050 |
Why?
|
Prognosis | 2 | 2017 | 28919 | 0.050 |
Why?
|
Nuclear Proteins | 1 | 2015 | 5982 | 0.050 |
Why?
|
Muscle Cells | 1 | 2019 | 200 | 0.040 |
Why?
|
Stem Cell Niche | 1 | 2022 | 342 | 0.040 |
Why?
|
Leukocytosis | 1 | 2019 | 255 | 0.040 |
Why?
|
Receptors, Leptin | 1 | 2019 | 344 | 0.040 |
Why?
|
Myocardial Infarction | 2 | 2019 | 11323 | 0.040 |
Why?
|
RNA Interference | 2 | 2018 | 3026 | 0.040 |
Why?
|
E2F1 Transcription Factor | 1 | 2018 | 195 | 0.040 |
Why?
|
DNA Methylation | 1 | 2011 | 4099 | 0.040 |
Why?
|
Sentinel Lymph Node Biopsy | 1 | 2021 | 654 | 0.040 |
Why?
|
Macrophages, Alveolar | 1 | 2019 | 441 | 0.040 |
Why?
|
Epidermal Growth Factor | 1 | 2020 | 724 | 0.040 |
Why?
|
Keratins | 1 | 2018 | 534 | 0.040 |
Why?
|
Connexin 43 | 1 | 2017 | 220 | 0.040 |
Why?
|
Octamer Transcription Factor-3 | 1 | 2017 | 243 | 0.040 |
Why?
|
Genome-Wide Association Study | 1 | 2015 | 11738 | 0.040 |
Why?
|
Blotting, Western | 2 | 2015 | 5456 | 0.040 |
Why?
|
Cell Count | 1 | 2019 | 1920 | 0.030 |
Why?
|
Aged | 3 | 2018 | 161488 | 0.030 |
Why?
|
Gene Library | 1 | 2018 | 1094 | 0.030 |
Why?
|
Transcription Factors | 1 | 2015 | 12005 | 0.030 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2015 | 15485 | 0.030 |
Why?
|
Chromosomes | 1 | 2018 | 614 | 0.030 |
Why?
|
Open Reading Frames | 1 | 2018 | 840 | 0.030 |
Why?
|
Organ Specificity | 1 | 2019 | 2064 | 0.030 |
Why?
|
Child, Preschool | 1 | 2017 | 41081 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2019 | 14075 | 0.030 |
Why?
|
Cytoplasmic Granules | 1 | 2017 | 627 | 0.030 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2019 | 2635 | 0.030 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2017 | 745 | 0.030 |
Why?
|
RNA, Neoplasm | 1 | 2017 | 780 | 0.030 |
Why?
|
Drug Delivery Systems | 2 | 2019 | 2277 | 0.030 |
Why?
|
Antigen-Presenting Cells | 1 | 2017 | 981 | 0.030 |
Why?
|
Adult | 3 | 2018 | 211041 | 0.030 |
Why?
|
Cell Growth Processes | 1 | 2014 | 413 | 0.030 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2020 | 1233 | 0.030 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2011 | 4865 | 0.030 |
Why?
|
Fatty Acids | 1 | 2021 | 1741 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 1 | 2015 | 17218 | 0.030 |
Why?
|
Cells, Cultured | 2 | 2022 | 20170 | 0.030 |
Why?
|
Microarray Analysis | 1 | 2015 | 777 | 0.030 |
Why?
|
Apoptosis | 3 | 2015 | 10085 | 0.030 |
Why?
|
Interleukin-10 | 1 | 2018 | 1213 | 0.030 |
Why?
|
Oncogenes | 1 | 2018 | 1244 | 0.030 |
Why?
|
Microscopy, Electron | 1 | 2015 | 2881 | 0.030 |
Why?
|
Mice, Mutant Strains | 1 | 2015 | 1956 | 0.030 |
Why?
|
Polymers | 1 | 2019 | 1672 | 0.030 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2012 | 11253 | 0.030 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 2012 | 315 | 0.030 |
Why?
|
Leukocytes | 1 | 2019 | 2095 | 0.030 |
Why?
|
Heart Atria | 1 | 2017 | 1286 | 0.030 |
Why?
|
Gene Expression Regulation | 2 | 2020 | 12447 | 0.030 |
Why?
|
Small Molecule Libraries | 1 | 2017 | 732 | 0.030 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2017 | 5197 | 0.030 |
Why?
|
Gene Regulatory Networks | 1 | 2019 | 1712 | 0.030 |
Why?
|
Liver | 1 | 2007 | 7622 | 0.030 |
Why?
|
Lung Neoplasms | 2 | 2012 | 12183 | 0.030 |
Why?
|
Mice, Knockout | 2 | 2018 | 15274 | 0.030 |
Why?
|
Ischemia | 1 | 2019 | 1934 | 0.020 |
Why?
|
Homeodomain Proteins | 1 | 2019 | 2459 | 0.020 |
Why?
|
Child | 1 | 2017 | 73636 | 0.020 |
Why?
|
Collagen Type I | 1 | 2012 | 576 | 0.020 |
Why?
|
Paclitaxel | 1 | 2017 | 1655 | 0.020 |
Why?
|
Middle Aged | 4 | 2018 | 213752 | 0.020 |
Why?
|
Chromosome Mapping | 1 | 2018 | 4837 | 0.020 |
Why?
|
Antigens, Neoplasm | 1 | 2017 | 2003 | 0.020 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2012 | 680 | 0.020 |
Why?
|
Neoplastic Stem Cells | 1 | 2017 | 1392 | 0.020 |
Why?
|
B-Lymphocytes | 1 | 2022 | 4861 | 0.020 |
Why?
|
Models, Animal | 1 | 2015 | 2221 | 0.020 |
Why?
|
Pneumonia | 1 | 2019 | 2080 | 0.020 |
Why?
|
Myocytes, Cardiac | 1 | 2017 | 1641 | 0.020 |
Why?
|
Tissue Distribution | 1 | 2012 | 2428 | 0.020 |
Why?
|
Male | 7 | 2020 | 349524 | 0.020 |
Why?
|
Adipose Tissue | 1 | 2019 | 3234 | 0.020 |
Why?
|
RNA-Binding Proteins | 1 | 2017 | 1920 | 0.020 |
Why?
|
Signal Transduction | 3 | 2020 | 23950 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2015 | 5045 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2020 | 4254 | 0.020 |
Why?
|
Sleep | 1 | 2022 | 4143 | 0.020 |
Why?
|
Fibroblasts | 1 | 2018 | 4299 | 0.020 |
Why?
|
CpG Islands | 1 | 2011 | 1177 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2019 | 3558 | 0.020 |
Why?
|
Genes, Tumor Suppressor | 1 | 2011 | 1095 | 0.020 |
Why?
|
Homeostasis | 1 | 2018 | 3334 | 0.020 |
Why?
|
Genotype | 1 | 2021 | 12863 | 0.020 |
Why?
|
Chromosomes, Mammalian | 1 | 2007 | 152 | 0.020 |
Why?
|
Tumor Burden | 1 | 2012 | 1906 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2011 | 2673 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2017 | 7026 | 0.020 |
Why?
|
Computer Simulation | 1 | 2019 | 6048 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2017 | 3026 | 0.020 |
Why?
|
Benzamides | 1 | 2011 | 1406 | 0.020 |
Why?
|
Stroke Volume | 1 | 2018 | 4522 | 0.020 |
Why?
|
Wound Healing | 1 | 2015 | 2800 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2015 | 3075 | 0.020 |
Why?
|
Exercise | 1 | 2019 | 5251 | 0.010 |
Why?
|
Neovascularization, Pathologic | 1 | 2014 | 2715 | 0.010 |
Why?
|
Antibodies, Neutralizing | 1 | 2012 | 1796 | 0.010 |
Why?
|
Odds Ratio | 1 | 2015 | 9754 | 0.010 |
Why?
|
Ovarian Neoplasms | 1 | 2019 | 4712 | 0.010 |
Why?
|
Cell Movement | 1 | 2015 | 5489 | 0.010 |
Why?
|
Genomics | 1 | 2018 | 5300 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2017 | 13314 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2017 | 5405 | 0.010 |
Why?
|
Gene Expression | 1 | 2014 | 8014 | 0.010 |
Why?
|
Piperazines | 1 | 2011 | 2532 | 0.010 |
Why?
|
Pyrimidines | 1 | 2011 | 2950 | 0.010 |
Why?
|
Hypertension | 1 | 2018 | 8161 | 0.010 |
Why?
|
Phenotype | 1 | 2014 | 16306 | 0.010 |
Why?
|
Heart Failure | 1 | 2018 | 10040 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2007 | 7965 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2012 | 61932 | 0.000 |
Why?
|
Concepts
(216)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(86)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_